Accelerated partial breast irradiation

Past, present, and future

Anne W. Tann, Sandra Hatch, Melissa Joyner, Lee Wiederhold, Todd Swanson

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Accelerated partial breast irradiation (APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life.

Original languageEnglish (US)
Pages (from-to)370-379
Number of pages10
JournalWorld Journal of Clinical Oncology
Volume7
Issue number5
DOIs
StatePublished - Oct 10 2016

Fingerprint

Breast
Cosmetics
Radiotherapy
Guidelines
Breast Neoplasms
Segmental Mastectomy
Brachytherapy
Patient Care
Appointments and Schedules
Therapeutics
Randomized Controlled Trials
Economics
Quality of Life
Radiation
Neoplasms

Keywords

  • Accelerated partial breast irradiation
  • Breast cancer
  • Interstitial brachytherapy
  • Intracavitary brachytherapy

ASJC Scopus subject areas

  • Oncology

Cite this

Accelerated partial breast irradiation : Past, present, and future. / Tann, Anne W.; Hatch, Sandra; Joyner, Melissa; Wiederhold, Lee; Swanson, Todd.

In: World Journal of Clinical Oncology, Vol. 7, No. 5, 10.10.2016, p. 370-379.

Research output: Contribution to journalReview article

Tann, Anne W. ; Hatch, Sandra ; Joyner, Melissa ; Wiederhold, Lee ; Swanson, Todd. / Accelerated partial breast irradiation : Past, present, and future. In: World Journal of Clinical Oncology. 2016 ; Vol. 7, No. 5. pp. 370-379.
@article{c0f652a66b7c4580bb064737efc84228,
title = "Accelerated partial breast irradiation: Past, present, and future",
abstract = "Accelerated partial breast irradiation (APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life.",
keywords = "Accelerated partial breast irradiation, Breast cancer, Interstitial brachytherapy, Intracavitary brachytherapy",
author = "Tann, {Anne W.} and Sandra Hatch and Melissa Joyner and Lee Wiederhold and Todd Swanson",
year = "2016",
month = "10",
day = "10",
doi = "10.5306/wjco.v7.i5.370",
language = "English (US)",
volume = "7",
pages = "370--379",
journal = "World Journal of Clinical Oncology",
issn = "2218-4333",
publisher = "Baishideng Publishing Group",
number = "5",

}

TY - JOUR

T1 - Accelerated partial breast irradiation

T2 - Past, present, and future

AU - Tann, Anne W.

AU - Hatch, Sandra

AU - Joyner, Melissa

AU - Wiederhold, Lee

AU - Swanson, Todd

PY - 2016/10/10

Y1 - 2016/10/10

N2 - Accelerated partial breast irradiation (APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life.

AB - Accelerated partial breast irradiation (APBI) focuses higher doses of radiation during a shorter interval to the lumpectomy cavity, in the setting of breast conserving therapy for early stage breast cancer. The utilization of APBI has increased in the past decade because of the shorter treatment schedule and a growing body of outcome data showing positive cosmetic outcomes and high local control rates in selected patients undergoing breast conserving therapy. Technological advances in various APBI modalities, including intracavitary and interstitial brachytherapy, intraoperative radiation therapy, and external beam radiation therapy, have made APBI more accessible in the community. Results of early APBI trials served as the basis for the current consensus guidelines, and multiple prospective randomized clinical trials are currently ongoing. The pending long term results of these trials will help us identify optimal candidates that can benefit from ABPI. Here we provide an overview of the clinical and cosmetic outcomes of various APBI techniques and review the current guidelines for selecting suitable breast cancer patients. We also discuss the impact of APBI on the economics of cancer care and patient reported quality of life.

KW - Accelerated partial breast irradiation

KW - Breast cancer

KW - Interstitial brachytherapy

KW - Intracavitary brachytherapy

UR - http://www.scopus.com/inward/record.url?scp=84991108181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991108181&partnerID=8YFLogxK

U2 - 10.5306/wjco.v7.i5.370

DO - 10.5306/wjco.v7.i5.370

M3 - Review article

VL - 7

SP - 370

EP - 379

JO - World Journal of Clinical Oncology

JF - World Journal of Clinical Oncology

SN - 2218-4333

IS - 5

ER -